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A transverse descriptive study was carried out, according to the classification of therapeutic compliance, 
to evaluate adherence in 250 patients with a diagnosis of Heart Failure, registered with the health 
department of the municipality of Santiago de Cuba in 2009. The sample characterization was studied, 
with an assessment of adherence level and possible associated factors for sex, age and toxic habits. As 
an instrument for the work, data extraction was scheduled and the interview was carried out at patients’ 
homes; the results were expressed in percentage and level of influence for associated factors. This was 
determined using the chi-square test. In the investigated population, adherence was greater for females, 
for age group 67-82 years, and toxic habits were found to have prevalence. Prevailing pharmacoterapies 
were digoxin, chlortalidone, captopril and isosorbide dinitrate, and a high level of adherence was found, 
both for the pharmacological and non-pharmacological treatments, in the studied sample. A good level 
of therapeutic adherence was found for 63.6% of the patients, regular level of adherence was found for 
32% and only 4.4% or patients presented with poor adherence. Influencing factors were: knowledge of 
the treatment, number of medications, frequency of administration, and satisfaction with the service of 
pharmaceutical care.
Uniterms: Treatment adherence. Heart failure/pharmacological treatment. Community pharmacy.
Realizou-se estudo descritivo transversal, de acordo com a classificação de adesão à terapêutica, para 
avaliar a adesão em 250 pacientes com diagnóstico de disfunção cardíaca, registrada no departamento 
de saúde do município de Santiago de Cuba, em 2009. A caracterização da amostra foi estudada, com 
a avaliação do nível de adesão e possíveis fatores associado a sexo, idade e hábitos tóxicos. Como 
instrumento para o trabalho, esquematizou-se aa extração de dados e realizou-se a entrevista nas moradias 
dos pacientes. Os resultados foram expressos em porcentagem e em nível de influência dos fatores 
associados, determinados por meio do teste do Q quadrado. Na população sob investigação, a adesão 
foi  maior para as mulheres da faixa etária de 67 a 82 anos, e os hábitos tóxicos foram prevalentes. Na 
amostra em estudo, as farmacoterapias predominantes foram digoxina, clortalidona, captopril e dinitrato 
de isossorbida e se observou alto nível de adesão tanto para os tratamentos farmacológicos quanto para 
os não-farmacológicos. Observou-se alto nível de adesão para 63,6% dos pacientes, nível regular para 
32% 3 somente 4,4% dos pacientes apresentaram baixa adesão. Os fatores que influenciaram foram 
conhecimento a respeito do tratamento, número de medicamentos, frequência de administração e satisfação 
com o serviço de atenção farmacêutica. 
Unitermos: Adesão terapêutica. Insuficiência cardíaca/tratamento farmacológico. Farmácia comunitária.
INTRODUCTION
Worldwide, cardiovascular diseases are among 
the leading causes of death. In 2010, cases of death all 
over the world increased by 36%, against 31% in 1999. 
Heart failure is a major and growing health problem, 
these days. The increase in heart failure incidence and 
prevalence, high morbidity and mortality, and the use of 
expensive resources constitute relevant challenges for 
modern day medicine. This is a chronic and progressive 
clinical syndrome. Incidences are increasing especially in 
industrialized countries, with extraordinary severity and 
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grim prognosis. In Cuba, it was the leading cause of death 
in patients over 60 years in 2005, with 16,248 patients 
suffering from cardiovascular diseases in our province 
jurisdiction (Orduñez et al., 2005).
Heart failure is also referred to as congestive heart 
failure. This is a disorder in which the heart loses its ability 
to efficiently pump blood, causing insufficient supply of 
oxygen and nutrients to the body, which leads to fatigue 
and shortness of breath (Tamargo, Delpón, 2001).
Pharmacological treatment and changes in lifestyle 
should be prescribed to patients with heart failure. Lack 
of adherence is the main factor in destabilization and 
hospitalization. Adherence is defined as the appropriate 
behavior for individuals who, ultimately and effectively 
validate the prescription by a health professional (Lora, 
2005).
Given that, our clinical services have conducted a 
study on prescribing and adherence for patients with heart 
failure. We were interested in investigating a larger number 
of patients and examining the factors that can influence 
adherence, a problem that results in the largest percentage 
of patients hospitalized for acute forms of this disease. 
Therefore, this study sets out to assess adherence in out-
patients with congestive heart failure in the health system.
METHOD
A descriptive study of drug use was conducted 
for adherence classification, according with Díaz, et at. 
(2004), so as to evaluate adherence of patients with heart 
failure in the health care system.
Sample characterization
A total of 250 patients were randomly selected for 
the sample, from a universe of 504 patients categorized 
in 2009 at the “Armando Garcia” health department (San-
tiago of Cuba). The sample was characterized according to 
social variables such as age, sex, and toxic habits relating 
to the pathology under study.
Level of adherence
All patients underwent an interview at their home 
(Annex I) which collected data on the variables and others 
aspects, as follows.
Drug treatment
This item specified compliance with the use of 
prescription medications for heart failure, including dose 
and frequency interval for each drug, as described in the 
medical certificate. 
Non-drug treatment
This item specified whether the patient met the 
dietary measures in terms of cutting down on salt and 
saturated fats, practicing physical activity according to 
their illness and limitating toxic habits (coffee, snuff and 
alcohol).
To determine the percentage of compliance for each 
patient, the following equation was used, at the discretion 
of researchers:
 (number of variables met x 100)
% Compliance = —————————————
 total variables
where total variables=6 (prescription medications, dose, 
interval, dietary measures, physical activity according to 
illness, and limitation of toxic habits)
Later, the following categories were established to 
define the level of adherence, according to the authors’ 
criteria:
Good adherence: For patients who achieved more than 
80% compliance. 
Regular adherence: For patients who achieved 50-80% 
compliance. 
Bad adherence: For patients who achieved less than 50% 
compliance. 
Factors associated with adherence
The possible factors associated with patient com-
pliance were analysed, with the aim of establishing the 
existence of an association between level of compliance 
and the possible factors, as follows:
A. Patient-dependent factors: sex, age, knowledge about 
the disease and treatment. 
B. Treatment-dependent factors: amount of medication 
and frequency of intake.
C. Health care-dependent factors: access to the Pharma-
ceutical Service, satisfaction with the care provided by 
the Pharmacy Services, and frequency of medical ap-
pointments.
Processing of results 
Absolute frequencies and percentages were used as 
a measure of summary for the qualitative variables. The 
statistical significance for dependency of the different fac-
tors was calculated using the test itself, and a parametric 
Chi-squared test (x2), in which adherence was the main 
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variable, and patient-dependent factors, treatment and 
pharmaceutical care were the independent variables.
RESULTS AND DISCUSSION
Sample characterization
The study included 250 patients with heart failure, 
of which 65.6% were women and 34.4% were men, as 
shown in Table I. The selected sample shows prevalence 
of women suffering from the disease. This result is in line 
with previous studies, but there are no reports that sex is 
a predisposing factor to the onset of heart failure (Roca, 
2002), so the result may be caused by the random selection 
of the sample, which included more women than men.
In terms of age group, the sample shows an in-
creased incidence of patients aged between 67-82 years, 
with 46.4% (Table I). This result can be attributed to the 
fact that, as age advances, there is a noticeable decrease 
in the stimulation of receptor ß - adrenergic, manifested 
by decrease in the inotropic, vasodilator and chronotropic 
response. Moreover, it has been reported that senescence 
causes a decline in cardiovascular function and that the 
severity of heart disease increases with age (Farreras, 
2000).
Level of therapeutic adherence
In terms of the level of adherence, Figure 1 shows 
that 63.6% of patients under study conformed well to the 
treatment. These results are consistent with the literature, 
in which compliance rates indicate that 40-60% of patients 
generally accept drug therapy. Regarding the drug treat-
ment, it was observed that all patients met the prescribed 
doses of medications used for heart failure, although 
some did not meet the specified intervals. This result 
can be attributed to the fact that, in this disease, multiple 
medications are tipically prescribed, and the frequency of 
administration is very high, so that patients are likely to 
stop their normal duties to take a dose, which could lead 
to neglect or refusal by patients.
When evaluating non-pharmacological treatment, 
we found that 97% of the sample adhered to the pre-
scribed plan of diet and physical activity. That was not 
the case, however, for the limitations of toxic habits, 
chiefly coffee intake. Although patients had acceptable 
knowledge about these restrictions, they failed to adhere 
to the prescribed indications. Given that coffee intake is 
not totally contraindicated in heart failure, we believe 
that the patients interviewed had made adjustments for 
major lifestyle changes that this disease requires (Al-
fonso, 2004).
Factors associated with therapeutic adherence
Table II shows the association of patient-dependent 
factors with the level of adherence. In terms of gender, 
there is a predominance of good adhesion in women, with 
42%. This finding is consistent with that reported in other 
studies, which have found criteria suggesting that women 
comply more with the treatment than men (Lifshitz, 2007), 
because they are more concerned about maintaining their 
FIGURE 1 - Level of therapeutic adherence of the patients with 
a diagnosis of heart failure.
TABLE I - Distribution of patients with cardiovascular disease, by age and sex
Age group 
(years)
Female Male Total
Number* % Number % Number %
31-50 5 2 4 1.6 9 3.6
51-66 30 12 20 8 50 20
67-82 71 28.4 45 18 116 46.4
≥ 83 58 23.2 17 6.8 75 30
total 164 65.6 86 34.4 250 100
* Number of the patients=250
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TABLE III - Age associated with therapeutic adherence
Age 
(years)
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
31-50 3 1.2 5 2 1 0.4 9 3.6
51-66 28 11.2 20 8 2 0.8 50 20
67-82 78 31.2 32 12.8 6 2.4 116 46.4
≥83 50 20 23 9.2 2 0.8 75 30
Total 159 63.6 80 32 11 4.4 250 100
x2=7.02    g.l=6    p > 0.05
TABLE II - Sex associated with therapeutic adherence
Sex
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Male 54 21.6 28 11.2 4 1.6 86 34.4
Female 105 42 52 20.8 7 2.8 91 36.4
Total 159 63.6 80 32 11 4.4 250 100
x2=0.05    g.l=2    p> 0.05
TABLE IV - Knowledge about the disease associated with therapeutic adherence
Knowledge 
about the 
disease
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Acceptable 127 50.8 63 25.2 7 2.8 197 78.8
Unacceptable 32 12.8 17 6.4 4 1.6 53 21.2
Total 159 63.6 80 32 11 4.4 250 100
x2=1.62    g.l=2    p> 0.05
health. However, the characteristics of the sample may be 
influencing the results, as the statistical analysis (p > 0.05) 
did not reflect the level of adherence depending on this 
factor.
In analyzing the impact of age groups (Table III), 
there was no significant dependency (p> 0.05) with the 
level of adherence. We must bear in mind that, at any 
age, patients with chronic diseases should be given their 
medication and follow appropriate changes in lifestyle, 
which will maintain the disease stable. 
Significant influence (p > 0.05) was not found from 
the knowledge of the disease (Table IV). However, it 
was observed that 78.8% of the patients have acceptable 
knowledge about their disease. This result is in line with 
other studies, which establishes the importance of each 
patient knowing the broader aspects of their pathology, 
which should prompt them to adopt positive behavior in 
terms of their medication and lifestyle.
In terms of the factor knowledge about the treatment 
(Table V), a statistically significant dependency (p < 0.05) 
was observed, with 85% of patients having achieved accept-
able knowledge about their treatment dose and interval. This 
result coincides with other reports, which have shown that 
a better understanding of the disease and treatment brings 
better adherence. (Noda, et al., 2008; Alfonso, 2006).
Treatment-dependent factors are presented in Tables 
VI and VII, and it was observed that the number of medica-
tions and frequency of administration significantly influ-
enced (p < 0.05) the level of adherence. We found that most 
patients who achieved a good level of adherence consumed 
up to 3 drugs, up to 3 times a day. This result could be due to 
the fact that, even with multiple medications, patients must 
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TABLE V - Knowledge about the treatment associated with therapeutic adherence
Knowledge 
about the 
treatment
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Acceptable 136 54.4 72 28.8 6 2.4 214 85.6
Unacceptable 23 9.2 8 3.2 5 2 36 14.4
Total 159 63.6 80 32 11 4.4 250 100
x2=9.86    g.l=2    p < 0.05
TABLE VI - Amount of medication associated with therapeutic adherence
Amount of 
Medication
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
≤ 3 99 39.6 25 10 4 1.6 128 51.2
≥ 4 60 24 55 22 7 2.8 122 48.8
Total 159 63.6 80 32 11 4.4 250 100
x2=21.50    g.l=2    p < 0.05
TABLE VII - Frequency of administration associated with therapeutic adherence
Frequency of 
administration
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
≤ 3 151 60.4 69 27.6 8 3.2 228 91.2
≥ 4 8 3.2 11 4.4 3 1.2 22 8.8
Total 159 63.6 80 32 11 4.4 250 100
x2=9.93    g.l=2    p < 0.05
TABLE VIII - Access to the Pharmaceutical Service associated with therapeutic adherence
Access to the 
pharmaceutical 
service
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Acceptable 83 33.2 47 18.8 8 3.2 138 55.2
Unacceptable 76 30.4 33 13.2 3 1.2 112 44.8
Total 159 63.6 80 32 11 4.4 250 100
x2=2.35    g.l=2    p > 0.05
comply with the treatment, once non-compliance can lead 
to recurrent decompensation, with subsequent hospitaliza-
tions. It is known that heart failure requires the use of several 
drugs. In our study, the most representative therapeutic regi-
men was the one that prescribed digoxin, chlorthalidone, 
isosorbide dinitrate, and captopril(14).
With respect to care-dependent factors (Table VIII), 
it was observed that access to the pharmaceutical service 
was not an influencing factor (p > 0.05) in adherence, 
because patients can fill their prescriptions at pharmacies 
near their home/community. Additionally, the patients who 
showed inadequate access can still obtain their drugs be-
cause, although they are unable to run errands themselves, 
they usually send a family member to get their medication. 
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The assessment of patient satisfaction (Table XIX) 
showed significant dependency (p < 0.05) with the level 
of adherence. It was observed that the largest number of 
patients with good adherence showed high satisfaction 
with the pharmacy services, which suggests that patient 
care regarding treatment, frequency intervals, clarifica-
tions, and doubts may affect proper enforcement.
The frequency of medical examination showed no 
significant dependency (Table X) with regard to adherence 
to the treatment, and it was observed that 50.8% of patients 
with good adherence had an inadequate rate of appoint-
ments with a doctor. Patients only visit the doctor to obtain 
their drug prescriptions, in acute episodes or for other oc-
casional causes. In this respect, some authors suggest that 
to increase adherence should be from the education and 
professional preparation of health to develop compelling 
communication, affective and effective, to simplify treat-
ment regimens as well as schedule frequency of patient 
visits to allow for appropriate interaction between health 
care professionals and patient (Sedano,2009).
Of the factors analyzed, only one significantly influ-
enced adherence, namely patient’s knowledge about the 
treatment. Among patients, 85.6% achieved acceptable 
knowledge about their treatment, which coincides with 
other reports which have shown that a better understand-
ing of the disease and treatment cause better adherence to 
the treatment.
Treatment-dependent: in terms of the number of 
medications and frequency of administration, it was found 
that most patients who achieved a good level of adherence 
consume up to 3 drugs, up to 3 times a day.
Care-dependent: in terms of patient satisfaction, it 
was observed that patients with good adherence expressed 
high satisfaction with the pharmacy service. It has been 
reported that patient satisfaction, from an emotional 
viewpoint on the relationship established with health pro-
fessionals, has been associated with increased adherence 
(Heredia, Megret, 2005).
Despite the prevailing good adherence, we consider 
it necessary for health professionals to provide health 
education to patients with heart failure, especially the pro-
fessional pharmacist, thus helping improve these patients’ 
quality of life.
The biggest problem for adherence studies is that 
there no “gold standard” for fully measuring this pattern 
of behavior. The boundaries between good and poor adher-
ence are not uniformly defined, and therefore any system 
that is used only in practice will provide a more or less 
accurate approximation of the real situation.
CONCLUSIONS
In the investigated population, there was prevalence 
of women, of the age group of 67-82 years and a greater 
TABLE IX - Satisfaction with care in the Pharmacy Services associated with therapeutic adherence
Satisfaction 
with care in 
the pharmacy 
services
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Low 11 4.4 10 4 2 0.8 23 9.2
Media 70 28 18 7.2 3 1.2 91 36.4
High 78 31.2 52 20.8 6 2.4 136 54.4
Total 159 63.6 80 32 11 4.4 250 100
x2=12.34    g.l=4    p < 0.05
TABLE X - Frequency of medical visits associated with therapeutic adherence
Frequency of 
medical visits
Good therapeutic 
adherence
Regular therapeutic 
adherence
Bad therapeutic 
adherence Total
Number % Number % Number % Number %
Acceptable 32 12.8 15 6 5 2 52 20.8
Unacceptable 127 50.8 65 26 6 2.4 198 79.2
Total 159 63.6 80 32 11 4.4 250 100
x2=4.31    g.l=2    p> 0.05
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incidence of coffee intake as a toxic habit. The prevailing 
pharmacoterapy was digoxin, chlortalidone, captopril and 
isosorbide dinitrate. A good level of therapeutic adherence 
was observed in the patients. This level of adherence was 
influenced by factors such as knowledge about the treat-
ment, number of medications, frequency of administration, 
and satisfaction with the care in the pharmacy service. 
Most of the investigated patients adopted positive behav-
iors that allowed for good adherence to the treatment.
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Annex I
Patient interview
Patient:  _____________________________________________________________________________________
You are participating in an investigation pertaining to the Pharmaceutical Service; your information will help improve 
services and patient education information provided by the pharmacy, which will ensure rational use of medication. 
Thank you for your cooperation.
Are you taking medications for heart failure in the amount (dose) prescribed by your doctor?
Medication  Dosage
___________________________________________________________________  ______________  
Did you manage to take medications for heart failure  in the schedule (dosing interval)?
Range  Drug
___________________________________________________________________  ______________
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What do you do when you forget to take any medication?
 I do not take it  I take the double dose      I take it when I remember
Have you stopped taking their medication at some point?
 Yes  No When _______________________________
Why? ______________________________________________________________
What quantity of salt you add to your food?     Little  Average  A lot 
Which type of fat you use?     Oil  Fats
Has your doctor forbidden any kind of physical exercise, due to your disease? Which? 
 Walking  Bicycling  Climbing stairs  None
Do you drink coffee? 
 No  Yes  1-2 cups/day  3-4 cups/day  More
Do you drink alcohol?    Yes     No
Do you smoke?    Yes     No
Do you know about your disease?    Yes     No
Do you know why you are taking medication for your heart treatment?
 Yes  No A little_______________________________
Do you get the medication from the pharmacy?    Yes     No
Are you satisfied with the care provided by the Pharmacy Department? 
 Not much  Average  Completely satisfied 
How often do you visit your family doctor? ________________________________
